Great work @Quiltman,
Given the recent MPL ODD Approval, as you said, after showing positive results in NfL’s in addition to ALSFRS-R, maybe FTD could be one of the Neurodegenerative diseases we test in preclinical trials if we can be assisted with funding from:
https://www.alzdiscovery.org/news-room/announcements/alzheimers-drug-discovery-foundation-addf-and-association-for-frontotemporal-degeneration-aftd-extend-treat-ftd-fund-through-2035
Ann: PharmAust receives Orphan Drug Designation for monepantel, page-44
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.3¢ |
Change
-0.013(6.41%) |
Mkt cap ! $91.16M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.0¢ | 18.0¢ | $127.8K | 690.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 419025 | 18.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.5¢ | 205062 | 7 |
View Market Depth
| Last trade - 14.54pm 05/08/2024 (20 minute delay) ? |
| PAA (ASX) Chart |